← Back to Search

Enhanced PROM Strategy for Patient-Reported Outcomes

N/A
Recruiting
Led By David Ring, MD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Language other than English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new way of making health surveys more relevant and easier for patients. It aims to improve patient experience by simplifying questions, addressing concerns, and clearly summarizing results.

Who is the study for?
This trial is for new patients who can communicate in English or Spanish. It's not suitable for individuals with cognitive issues that prevent them from completing patient-reported outcome measures (PROMs).
What is being tested?
The study compares the usual way of collecting PROMs with an enhanced strategy to see if it improves how often patients complete these health questionnaires.
What are the potential side effects?
There are no direct side effects associated with this trial as it involves answering questions about personal health experiences rather than testing a medical treatment.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I speak a language other than English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of 3-survey patient-reported outcome measure at 6-week follow-up via Text
Completion of answered text
Completion of deprioritization options 1 or 2 at 6-week follow-up via text or email
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Patients randomized to intervention receive both usual Patient reported outcome measure (PROM) and new PROMs strategy (on the technology platform for English speakers and on REDCap/Qualtrix for Spanish Speakers) done after rooming.
Group II: Control groupActive Control1 Intervention
Patients go through the registration process which includes PROMs completion using Ipads. Enrolled in the room at the end of the visit.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for improving Patient-Reported Outcome Measures (PROMs) focus on enhancing the relevance, personalization, and logistical efficiency of the data collection process. Mechanisms of action include tailoring questionnaires to address specific patient concerns, ensuring that the questions are directly relevant to the patient's condition and treatment goals, and streamlining the administration process to reduce burden and improve completion rates. These improvements matter because they lead to more accurate and meaningful data, which can better inform clinical decisions and ultimately enhance patient care and outcomes.
Patient-Reported Outcomes Measurement Information System physical function instruments compare favorably to legacy patient-reported outcome measures in spine patients: a systematic review of the literature.COHESION: core outcomes in neonatal encephalopathy (protocol).What Is the Impact of the COVID-19 Pandemic on Quality of Life and Other Patient-reported Outcomes? An Analysis of the Hand-Wrist Study Cohort.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
375 Previous Clinical Trials
86,050 Total Patients Enrolled
David Ring, MDPrincipal InvestigatorProfessor of orthopedic surgery at The university of Texas at Austin
4 Previous Clinical Trials
294 Total Patients Enrolled
~89 spots leftby Dec 2025